CN Patent

CN118745158B — 三嗪环衍生物、其制备方法及其应用和pdgfr激酶抑制剂

Assigned to Sichuan Academy Of Medical Sciences Sichuan Provincial People's Hospital · Expires 2026-02-03 · 0y expired

What this patent protects

本发明涉及化合物制备技术领域，具体而言，涉及三嗪环衍生物、其制备方法及其应用和PDGFR激酶抑制剂。三嗪环衍生物的结构式如下所示： 其中，R 1 和R 2 分别选自取代苯基。该三嗪环衍生物对PDGFR激酶有抑制效果，可以作为PDGFR激酶抑制剂，并对相关的肿瘤也有抑制效果。

USPTO Abstract

本发明涉及化合物制备技术领域，具体而言，涉及三嗪环衍生物、其制备方法及其应用和PDGFR激酶抑制剂。三嗪环衍生物的结构式如下所示： 其中，R 1 和R 2 分别选自取代苯基。该三嗪环衍生物对PDGFR激酶有抑制效果，可以作为PDGFR激酶抑制剂，并对相关的肿瘤也有抑制效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN118745158B
Jurisdiction
CN
Classification
—
Expires
2026-02-03
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Academy Of Medical Sciences Sichuan Provincial People's Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.